TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26002520

Group type: EXPERIMENTAL
Intervention: Multifaceted education intervention
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 3
Study: 23001939

Group type: EXPERIMENTAL
Intervention: Catechin-rich oil palm leaf extract (OPLE) 0.5 g day(‐1)
Number of subjects: 15
Study: 21110694

Group type: EXPERIMENTAL
Intervention: 7 weeks of low-intensity norm duration hand rim wheelchair training, 3 times a week at 30% heart rate reserve (HRR) for 30 min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 25
Study: 18199182

Group type: EXPERIMENTAL
Intervention: Nonviolent resistance (NVR) training
Number of subjects: 73

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 73
Study: 17294997

Group type: EXPERIMENTAL
Intervention: Intramuscular 1 mg/kg tramadol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intramuscular 1 mg/kg meperidine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intramuscular 0.5 mg/kg ketamine
Number of subjects: 45
Study: 12590905

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 10377734

Group type: EXPERIMENTAL
Intervention: Combined therapy with interferon-alpha-2b (3 MU, three times a week) and ribavirin (1000-1200 mg daily) for one year
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined therapy with interferon-alpha-2b and ribavirin
Number of subjects: 100
Study: 8927233

Group type: EXPERIMENTAL
Intervention: Amantadine (AMA) 100 mg, tid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Biperiden (BIP) 2 mg, tid
Number of subjects: 42
Study: 1712193

Group type: EXPERIMENTAL
Intervention: Moricizine 750 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Disopyramide 600 mg/day
Number of subjects: 10
Study: 7112396

Group type: EXPERIMENTAL
Intervention: Preoperative intralymphatic immunotherapy with MER-BCG, surgical excision with regional lymphadenectomy, and postoperative monthly intradermal vaccinations with BCG
Number of subjects: 25

Group type: COMPARATOR
Intervention: Surgery and lymphadenectomy alone
Number of subjects: 25
Study: 30522922

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (1.8 mg/kg) + cyclophosphamide (750 mg/m2) + doxorubicin (50 mg/m2) + prednisone (100 mg) (A+CHP)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Cyclophosphamide (750 mg/m2) + doxorubicin (50 mg/m2) + vincristine (1.4 mg/m2) + prednisone (100 mg) (CHOP)
Number of subjects: 452
Study: 29981285

Group type: EXPERIMENTAL
Intervention: Roxadustat + Lanthanum Carbonate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Roxadustat alone
Number of subjects: 18
Study: 27716168

Group type: EXPERIMENTAL
Intervention: Transforaminal lumbar interbody fusion (TLIF)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 144
Study: 25106776

Group type: EXPERIMENTAL
Intervention: Honey plus Coffee (HC)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Topical Steroid (S)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Honey (H)
Number of subjects: 75
Study: 22186114

Group type: EXPERIMENTAL
Intervention: Tight-bound (TB) abdominal binding
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Loose-bound (LB) abdominal binding
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unbound (UB) abdominal binding
Number of subjects: 13

Group type: COMPARATOR
Intervention: Able-bodied controls
Number of subjects: 13
Study: 19282246

Group type: COMPARATOR
Intervention: Dementia-care mapping
Number of subjects: 289

Group type: COMPARATOR
Intervention: Person-centred care
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Usual care
Number of subjects: 289
Study: 18003042

Group type: EXPERIMENTAL
Intervention: Music group (n=12)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n=14)
Number of subjects: 30
Study: 16117818

Group type: EXPERIMENTAL
Intervention: r‐HuEPO (50 U/kg, administered three times a week for 25 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12191566

Group type: EXPERIMENTAL
Intervention: 25mg TNFR:Fc administered twice a week for 10 weeks
Number of subjects: 10
Study: 10192108

Group type: EXPERIMENTAL
Intervention: Test preparation (enteric coated capsule containing 90 mg peppermint oil and 50 mg caraway oil)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Reference preparation (enteric soluble formulation containing 36 mg peppermint oil and 20 mg caraway oil)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Test preparation
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 223
Study: 7766746

Group type: COMPARATOR
Intervention: Ispaghula, 3.5 g twice a day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vancomycin, 250 mg t.d.s. per os
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 8
Study: 1980220

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7026400

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31177240

Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements (eyes-open)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements (eyes-closed)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Function in Sitting Test (FIST)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinical sitting balance measurement (FIST)
Number of subjects: 60
Study: 29870855

Group type: EXPERIMENTAL
Intervention: PCT-guided therapy (n=275)
Number of subjects: 551

Group type: COMPARATOR
Intervention: Standard diagnostic workup (control group, n=276)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: PCT for confirmed bacterial infections
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: CRP for confirmed bacterial infections
Number of subjects: 551
Study: 27075841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol + Exercise Training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 0
Study: 24623067

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (10,000 IU day(‐1))
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (visually identical)
Number of subjects: 29
Study: 22541305

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) as an adjunct to eccentric exercises
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment as an adjunct to eccentric exercises
Number of subjects: 40
Study: 19074534

Group type: EXPERIMENTAL
Intervention: MDMA (100 mg) with ethanol (0.6 per thousand)
Number of subjects: 16

Group type: COMPARATOR
Intervention: MDMA (100 mg) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ethanol (0.6 per thousand) alone
Number of subjects: 16
Study: 17711566

Group type: EXPERIMENTAL
Intervention: remifentanil 1 microg/kg
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: alfentanil 10 microg/kg
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: fentanyl 2 microg/kg
Number of subjects: 164

Group type: COMPARATOR
Intervention: saline
Number of subjects: 164
Study: 15124006

Group type: EXPERIMENTAL
Intervention: TPH2 gene SNP analysis in depressed patients
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Haplotype analysis in depressed patients
Number of subjects: 565

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 565
Study: 12235444

Group type: EXPERIMENTAL
Intervention: Phenytoin alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Phenytoin with losartan
Number of subjects: 16

Group type: COMPARATOR
Intervention: Losartan alone
Number of subjects: 16
Study: 9832660

Group type: EXPERIMENTAL
Intervention: In-person triage interviews conducted by certified ED triage nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone triage interviews conducted by certified ED triage nurses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of complaint-based protocols in phase 2
Number of subjects: 0
Study: 7859051

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide 2.5-5.0 mg
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Enalapril 10-20 mg
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 114
Study: 2698934

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg twice a day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg once a day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nifedipine + Chlorthalidone (both at the same doses)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 779554

Group type: EXPERIMENTAL
Intervention: Atropine sulfate 0.1 mg per kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30768766

Group type: EXPERIMENTAL
Intervention: Once daily subcutaneous semaglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once daily 3.0 mg liraglutide
Number of subjects: 0
Study: 28034079

Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 25171889

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy for primary care (PST-PC)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Coaching in healthy dietary practices (DIET)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Both PST-PC and DIET
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Higher social problem-solving and physical functioning
Number of subjects: 247
Study: 23756082

Group type: EXPERIMENTAL
Intervention: SWLP + MI
Number of subjects: 54

Group type: COMPARATOR
Intervention: SWLP
Number of subjects: 54
Study: 21763950

Group type: EXPERIMENTAL
Intervention: Mainstream schools
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Special education centers
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Overall prevalence
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Most frequent diagnoses
Number of subjects: 1158
Study: 19356905

Group type: EXPERIMENTAL
Intervention: Bio‐Gide membrane
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Connective tissue graft
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Full‐thickness palatal mucosa graft
Number of subjects: 45
Study: 16377062

Group type: EXPERIMENTAL
Intervention: r-FSH alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: r-FSH and r-LH
Number of subjects: 40
Study: 15333274

Group type: EXPERIMENTAL
Intervention: Full questionnaire (General Health Questionnaire‐12, PTSD checklist, self-assessed health status, alcohol behaviour questions)
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: Abridged questionnaire (GHQ‐4, shortened PTSD checklist, fewer symptoms, no alcohol behaviour questions)
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: Screen-positive individuals invited to attend a medical centre
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Servicemen with PTSD, alcohol behaviour, or multi-criteria 'screen-positive'
Number of subjects: 4500
Study: 17290039

Group type: EXPERIMENTAL
Intervention: Fluticasone 500 microg, twice a day
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 10365628

Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) administered to psychiatric patients
Number of subjects: 1547

Group type: COMPARATOR
Intervention: Social Support Questionnaire (SSQ) administered to healthy controls
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) for patients with anxiety disorder, mood disorder, schizophrenia, and V codes
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) for schizophrenic patients
Number of subjects: 1547
Study: 8896396

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF; 5 micrograms/kg) plus stem cell factor (SCF; 20 micrograms/kg) after chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy and G-CSF alone
Number of subjects: 0
Study: 1858035

Group type: EXPERIMENTAL
Intervention: Open file interview (290 candidates)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Blinded interview (133 candidates)
Number of subjects: 423
Study: 7095850

Group type: EXPERIMENTAL
Intervention: 50 micrograms of type 19F polysaccharide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 micrograms of type 19A polysaccharide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 micrograms of both polysaccharides premixed in a single injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 19F polysaccharide antigen
Number of subjects: 0
Study: 31774028

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone
Number of subjects: 19
Study: 31093657

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 694

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 694
Study: 29347874

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg per day)
Number of subjects: 3800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3800
Study: 26775609

Group type: EXPERIMENTAL
Intervention: Drawing before dissection
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Drawing after dissection
Number of subjects: 416

Group type: COMPARATOR
Intervention: No drawing (control group)
Number of subjects: 416
Study: 25179916

Group type: EXPERIMENTAL
Intervention: RCT-18 (1.2, 6, 18, 60, 180, 360, 540 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: RCT-18 (540 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: RCT-18 (180, 360, 540 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 22445946

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Mood induction paradigm
Number of subjects: 523
Study: 19181786

Group type: EXPERIMENTAL
Intervention: h‐ATG/CsA/sirolimus
Number of subjects: 77

Group type: COMPARATOR
Intervention: h‐ATG/CsA
Number of subjects: 77
Study: 17062764

Group type: EXPERIMENTAL
Intervention: High-fat (HF) diet (75% energy as fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet (35% energy as fat)
Number of subjects: 10
Study: 15646430

Group type: EXPERIMENTAL
Intervention: Dioctahedral smectite (3 g, three sachets, administered 1 h after meals for 28 days)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Probiotic preparation (Bifico 210 mg, two capsules for 28 days)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Dioctahedral smectite
Number of subjects: 410

Group type: COMPARATOR
Intervention: Probiotic preparation
Number of subjects: 410
Study: 11825347

Group type: EXPERIMENTAL
Intervention: Postal questionnaires
Number of subjects: 315

Group type: COMPARATOR
Intervention: Hospital records
Number of subjects: 315
Study: 9541126

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (180 mmol fatty acids)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (180 mmol fatty acids)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (90 mmol fatty acids)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sucrose polyester (90 mmol fatty acids)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 8
Study: 7925518

Group type: EXPERIMENTAL
Intervention: Nisoldipine (20 mg once daily, n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 32
Study: 2511299

Group type: EXPERIMENTAL
Intervention: Usual dosage of lithium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reduced lithium dosage by up to 50%
Number of subjects: 0
Study: 30591410

Group type: EXPERIMENTAL
Intervention: Partial Better Match (PBM) protocol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Extended Match (EM) protocol
Number of subjects: 18
Study: 28645957

Group type: EXPERIMENTAL
Intervention: Viewing an e-cigarette advertisement
Number of subjects: 150

Group type: COMPARATOR
Intervention: Neutral image
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Attitudes towards e-cigarettes
Number of subjects: 150
Study: 25561281

Group type: EXPERIMENTAL
Intervention: Blood Purification (BP) treatment
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (conventional therapy only)
Number of subjects: 195
Study: 23116458

Group type: EXPERIMENTAL
Intervention: 3.6 mg MSF
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 7.2 mg MSF
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10.8 mg MSF
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 22011895

Group type: EXPERIMENTAL
Intervention: 0.05% sodium hypochlorite (NaOCl)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Medical Interporous (MI)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Distilled water (DW)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Periogard (PE)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cepacol (CE)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Corega Tabs (CT)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Polident (PO)
Number of subjects: 5
Study: 19922132

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) 40,000 units, administered fortnightly for 24 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO)
Number of subjects: 23
Study: 16508590

Group type: EXPERIMENTAL
Intervention: 40 mg of olmesartan medoxomil once daily
Number of subjects: 4400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4400
Study: 12723832

Group type: EXPERIMENTAL
Intervention: Ferric sulfate pulpotomy (FS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 130
Study: 10661334

Group type: EXPERIMENTAL
Intervention: Chemotherapy before or after irradiation (n = 40 before, n = 15 after)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Complete resection (n = 28)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Incomplete resection (n = 27)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Localized tumors (no metastases at diagnosis)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Metastatic tumors (presence of metastases at diagnosis)
Number of subjects: 55
Study: 9339690

Group type: EXPERIMENTAL
Intervention: Pramipexole (up to 4.5 mg per day)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Bromocriptine (30 mg per day)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 8348063

Group type: EXPERIMENTAL
Intervention: Retinol, 25,000 international units/day
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Beta-carotene, 30 mg/day
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Retinol plus beta-carotene
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 1029
Study: 3521612

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 31785994

Group type: EXPERIMENTAL
Intervention: GLP‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: AGEs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AGEs + GLP‐1
Number of subjects: 0
Study: 29742937

Group type: EXPERIMENTAL
Intervention: Trabecular‐titanium cup
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional acetabular component
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups (trabecular‐titanium and conventional)
Number of subjects: 38
Study: 27277002

Group type: EXPERIMENTAL
Intervention: Bone Patellar Tendon Bone (BPTB) graft
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hamstring graft
Number of subjects: 100
Study: 25669003

Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia (Group U)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bilateral spinal anesthesia (Group B)
Number of subjects: 40
Study: 24312194

Group type: EXPERIMENTAL
Intervention: HIV‐DNA vaccine in addition to ongoing antiretroviral treatment (ART) (Group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ongoing antiretroviral treatment (ART) (Group A)
Number of subjects: 20
Study: 20167684

Group type: EXPERIMENTAL
Intervention: Median intradialytic BP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post6
Number of subjects: 0
Study: 18432528

Group type: EXPERIMENTAL
Intervention: High-dose polyestradiol phosphate (PEP; Estradurin) 240 mg i.m. twice a month for 2 months and thereafter monthly
Number of subjects: 910

Group type: COMPARATOR
Intervention: Combined androgen deprivation (CAD) with flutamide (Eulexin) 250 mg t.i.d. and triptorelin (Decapeptyl) 3.75 mg i.m. per month or bilateral orchidectomy
Number of subjects: 910
Study: 16174986

Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS) for chronic sinusitis in patients with asthma
Number of subjects: 88

Group type: COMPARATOR
Intervention: Endoscopic sinus surgery (ESS) for chronic sinusitis in patients without asthma
Number of subjects: 88
Study: 12854267

Group type: EXPERIMENTAL
Intervention: Calcium ascorbate (1 gram daily for 14 +/- 3 days)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo (identically looking tablets)
Number of subjects: 133
Study: 10535703

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 29

Group type: COMPARATOR
Intervention: Medical air (control)
Number of subjects: 29